Precision medicine testing for metastatic solid tumors before radiation
Part of Cancer clinical trials.
This trial is testing if a new type of genetic testing (Darwin OncoTreat and OncoTarget) can help guide radiation therapy for people whose cancer has spread to a limited number of spots in the body. The goal is to see if this approach is practical and beneficial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a solid tumor that has spread to a few other places in your body (up to 10 spots).
- All of the areas where your cancer has spread can be treated with focused radiation.
- Your blood counts, kidney function, and liver function are within a certain range.
- You are receiving radiation care at Good Samaritan University Hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with solid tumors that have spread to a few spots (5 or fewer) in the body. It tests whether using a focused treatment like radiation or ablation on those spots can help control the cancer long-term.
This Phase 2 study tests whether adding a very focused type of radiation to standard drug treatment can better control metastatic breast cancer. It is for people whose cancer is only progressing in one spot, seen on a PET scan.
This study tests whether a focused, high-precision type of radiation can control many cancer spread-out spots (“metastases”) at the same time, while keeping side effects acceptable. It may help people with many metastases live longer or have better disease control by aiming treatment at every treatable spot.
This trial tests whether using a personalized approach (matching your tumor's genetic profile to a targeted drug) can help people with advanced solid cancers live longer. It is for people whose cancer is not responding to standard treatments and who have a genetic change that can be targeted by an FDA-approved drug not usually used for their cancer type.
This trial tests a precise type of radiation that targets multiple tumor spots in a carefully planned way. It may help people with many metastatic (spread) solid tumors when standard treatments aren’t working or can’t be used.
This study uses advanced testing (molecular profiling and imaging) to better understand cancers and help guide treatment. It is for people with certain advanced cancers who have not yet had immunotherapy or targeted therapy.
Hear when a new Personalized Medicine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.